Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$5.47 - $8.78 $54,256 - $87,088
-9,919 Reduced 41.76%
13,833 $83,000
Q2 2023

Jul 13, 2023

SELL
$7.77 - $13.7 $777 - $1,370
-100 Reduced 0.42%
23,752 $199,000
Q1 2023

May 11, 2023

SELL
$9.22 - $13.3 $11,709 - $16,891
-1,270 Reduced 5.06%
23,852 $301,000
Q4 2022

Feb 08, 2023

BUY
$8.39 - $13.4 $839 - $1,340
100 Added 0.4%
25,122 $229,000
Q2 2022

Jul 13, 2022

SELL
$10.6 - $17.48 $11,448 - $18,878
-1,080 Reduced 4.14%
25,022 $321,000
Q1 2022

May 12, 2022

BUY
$12.24 - $24.07 $175,313 - $344,754
14,323 Added 121.6%
26,102 $440,000
Q4 2021

Feb 03, 2022

SELL
$20.7 - $29.49 $15,773 - $22,471
-762 Reduced 6.08%
11,779 $284,000
Q3 2021

Nov 02, 2021

BUY
$16.76 - $28.26 $210,187 - $354,408
12,541 New
12,541 $325,000

Others Institutions Holding SKIN

About Beauty Health Co


  • Ticker SKIN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 150,887,008
  • Market Cap $235M
  • Description
  • The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Hydra...
More about SKIN
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.